Literature DB >> 10538331

Costs of diabetes. A methodological analysis of the literature.

E Pagano1, M Brunetti, F Tediosi, L Garattini.   

Abstract

OBJECTIVE: To review studies on the costs of diabetes and its complications through a scheme designed specifically for assessing the quality of cost-of-illness (COI) studies. DESIGN AND
SETTING: The methodology of COI studies in diabetes was analysed in order to assess the significance of quantitative results. The scheme adopted 7 items identified as the main points for discussing the methodological choices governing the results. We also used a checklist based on questions related to the 7 items. MAIN OUTCOME MEASURES AND
RESULTS: The answers showed that many studies appear not to give technical details, so it is hard to understand the method. Methodological choices varied widely between the studies. This is probably due to the lack of consensus on the methodology of COI studies. Based on the findings of this review, we suggest also some specific points that could help produce more reliable results on the costs of diabetes.
CONCLUSIONS: Clearly, a general consensus on COI studies is still remote, making the value of any comparison of results questionable.

Entities:  

Mesh:

Year:  1999        PMID: 10538331     DOI: 10.2165/00019053-199915060-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  62 in total

1.  Financing the care of diabetes mellitus in the U.S. Background, problems, and challenges.

Authors:  E D Bransome
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

2.  Modelling in economic evaluation: an unavoidable fact of life.

Authors:  M J Buxton; M F Drummond; B A Van Hout; R L Prince; T A Sheldon; T Szucs; M Vray
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

3.  The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales.

Authors:  A Gray; P Fenn; A McGuire
Journal:  Diabet Med       Date:  1995-12       Impact factor: 4.359

4.  Differences in preferences between diabetic patients and diabetologists regarding quality of care: a matter of continuity and efficiency of care?

Authors:  A F Casparie; M A van der Waal
Journal:  Diabet Med       Date:  1995-09       Impact factor: 4.359

5.  Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation.

Authors:  B A Kiberd; K K Jindal
Journal:  BMJ       Date:  1995-12-16

6.  Cost-effectiveness of detecting and treating diabetic retinopathy.

Authors:  J C Javitt; L P Aiello
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

7.  Comparison of excess costs of care and production losses because of morbidity in diabetic patients.

Authors:  J Olsson; U Persson; C Tollin; S Nilsson; A Melander
Journal:  Diabetes Care       Date:  1994-11       Impact factor: 19.112

8.  Direct costs of diabetes care: a survey in Ottawa, Ontario 1986.

Authors:  J B McKendry
Journal:  Can J Public Health       Date:  1989 Mar-Apr

9.  Cost effectiveness of current approaches to the control of retinopathy in type I diabetics.

Authors:  J C Javitt; J K Canner; A Sommer
Journal:  Ophthalmology       Date:  1989-02       Impact factor: 12.079

10.  Structure and costs of health care of diabetic patients in Finland.

Authors:  T Kangas; S Aro; V A Koivisto; M Salinto; M Laakso; A Reunanen
Journal:  Diabetes Care       Date:  1996-05       Impact factor: 19.112

View more
  21 in total

1.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

2.  Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?

Authors:  Livio Garattini; Anna Padula
Journal:  J R Soc Med       Date:  2017-01-24       Impact factor: 5.344

Review 3.  Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.

Authors:  Christopher J Dunn; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Systematic review of economic burden of heart failure.

Authors:  Asrul Akmal Shafie; Yui Ping Tan; Chin Hui Ng
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

5.  Direct cost for initial management of prostate cancer: a systematic review.

Authors:  C Sanyal; A G Aprikian; S Chevalier; F L Cury; A Dragomir
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

Review 6.  Cost-of-illness studies for bipolar disorder: systematic review of international studies.

Authors:  Huajie Jin; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

7.  The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies.

Authors:  Jen Kruger; Alan Brennan
Journal:  Eur J Health Econ       Date:  2012-10-18

Review 8.  Cost of diabetic eye, renal and foot complications: a methodological review.

Authors:  Solène Schirr-Bonnans; Nadège Costa; Hélène Derumeaux-Burel; Jérémy Bos; Benoît Lepage; Valérie Garnault; Jacques Martini; Hélène Hanaire; Marie-Christine Turnin; Laurent Molinier
Journal:  Eur J Health Econ       Date:  2016-03-14

9.  Direct medical costs unequivocally related to diabetes in Italian specialized centers.

Authors:  Livio Garattini; Francesca Chiaffarino; Dante Cornago; Carlo Coscelli; Fabio Parazzini
Journal:  Eur J Health Econ       Date:  2004-02

Review 10.  Cost-of-illness studies in diabetes mellitus.

Authors:  Lorraine Ettaro; Thomas J Songer; Ping Zhang; Michael M Engelgau
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.